Matthew D Rousculp

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Topics

Coronavirus Disease

Affordable Care Act

Protein Protein

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Kyle Paret, Hadi Beyhaghi, William L Herring, Josephine Mauskopf, Lesley G Shane, Matthew D Rousculp
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States. Vaccines 12 (1) (2024)
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M Marchese, Mitra Montazeri, Shardul Odak, Laurin Jackson, Hadi Beyhaghi, Seth Toback
Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines. Vaccines 12 (7) (2024)
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M Marchese, Mitra Montazeri, Shardul Odak, Laurin Jackson, Angela Miller, Seth Toback
Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study. Vaccines 12 (1) (2024)
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M Marchese, Mitra Montazeri, Shardul Odak, Laurin Jackson, Angela Miller, Seth Toback
Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study. Vaccines 12 (1) (2024)
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M Marchese, Mitra Montazeri, Shardul Odak, Laurin Jackson, Angela Miller, Seth Toback
Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study. Vaccines 12 (1) (2024)
Kyle Paret, Hadi Beyhaghi, William L Herring, Josephine Mauskopf, Lesley G Shane, Matthew D Rousculp
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States. Vaccines 12 (1) (2024)
Kyle Paret, Hadi Beyhaghi, William L Herring, Josephine Mauskopf, Lesley G Shane, Matthew D Rousculp
Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States. Vaccines 12 (1) (2024)
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M Marchese, Mitra Montazeri, Shardul Odak, Laurin Jackson, Hadi Beyhaghi, Seth Toback
Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines. Vaccines 12 (7) (2024)
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M Marchese, Mitra Montazeri, Shardul Odak, Laurin Jackson, Hadi Beyhaghi, Seth Toback
Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines. Vaccines 12 (7) (2024)